Rapport Therapeutics, Inc. (RAPP) Insider Ownership

Historic Insider Ownership Trends

As of June 09, 2026, the three largest insider holders of RAPP are Rock Ventures V, L.P. Third (TenPercentOwner, 6.71Mn shares), Venture Partners Xii, Llc Arch (TenPercentOwner, 3.73Mn shares), James Healy (Director, 1.88Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Steven M Paul - 0 41,666 15 Sep, 2025
James Healy - 0 1,881,968 10 Jun, 2024
Troy A. Ignelzi Chief Financial Officer 10,000 0 13 Mar, 2025
Reid M Huber - 20,400 0 15 Sep, 2025
Abraham Ceesay Chief Executive Officer 556,247 20,729 19 Feb, 2026
Rock Ventures V, L.P. Third - 6,709,228 0 21 Apr, 2026
Cheryl Gault Chief Operating Officer 159,914 0 31 Mar, 2026
Venture Partners Xii, Llc Arch - 0 3,728,738 10 Jun, 2024
David Bredt Chief Scientific Officer 393,075 0 19 Feb, 2026
Krishnaswamy Yeleswaram Chief Development Officer 266,651 0 14 Apr, 2026
Wendy B. Young - 9,500 0 11 Sep, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
17 Apr, 2026 Rock Ventures V, L.P. Third Common Stock D 426,005 $40.32 6,709,228 D S
17 Apr, 2026 Rock Ventures V, L.P. Third Common Stock D 426,005 $40.32 6,709,228 D S
10 Apr, 2026 Krishnaswamy Yeleswaram Common Stock D 500 $34.98 286,016 D S
13 Apr, 2026 Krishnaswamy Yeleswaram Common Stock D 9,165 $34.97 276,851 D S
14 Apr, 2026 Krishnaswamy Yeleswaram Common Stock D 10,200 $35.08 266,651 D S
08 Apr, 2026 Krishnaswamy Yeleswaram Common Stock D 360 $34.90 286,516 D S
30 Mar, 2026 Cheryl Gault Common Stock D 7,161 $28.04 162,753 D S
30 Mar, 2026 Cheryl Gault Common Stock D 2,839 $28.55 159,914 D S
05 Mar, 2026 Cheryl Gault Common Stock D 2,014 $28.93 169,914 D S
18 Feb, 2026 Abraham Ceesay Common Stock D 3,552 $29.05 558,528 D S
17 Feb, 2026 David Bredt Common Stock D 900 $28.02 394,675 D S
17 Feb, 2026 David Bredt Common Stock D 5,400 $28.95 389,275 D S
18 Feb, 2026 Abraham Ceesay Common Stock D 2,281 $29.80 556,247 D S
17 Feb, 2026 David Bredt Common Stock D 2,200 $29.59 387,075 D S
18 Feb, 2026 Abraham Ceesay Common Stock D 2,983 $29.04 22,829 I S
18 Feb, 2026 Abraham Ceesay Common Stock D 2,100 $29.80 20,729 I S
19 Feb, 2026 David Bredt Common Stock A 6,000 $1.80 393,075 D M
19 Feb, 2026 David Bredt Stock Options (Right to Buy) D 6,000 $0.00 88,080 D M
02 Feb, 2026 Jeffrey Sevigny Stock Option (Right to Buy) A 130,000 $0.00 130,000 D A
02 Feb, 2026 Abraham Ceesay Stock Option (Right to Buy) A 428,000 $0.00 428,000 D A